Prenetics Global (NASDAQ:PRENW – Get Free Report) is expected to announce its resultson Thursday, May 14th. Analysts expect the company to announce earnings of ($0.8225) per share and revenue of $37.9030 million for the quarter.
Prenetics Global Price Performance
Shares of PRENW stock opened at $0.02 on Wednesday. Prenetics Global has a 12-month low of $0.01 and a 12-month high of $0.07. The firm has a fifty day moving average of $0.02 and a 200-day moving average of $0.02.
About Prenetics Global
Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.
Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.
Further Reading
- Five stocks we like better than Prenetics Global
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
